242 filings
Page 2 of 13
8-K
8figr23e6hc2mts1397
30 Dec 22
Departure of Directors or Certain Officers
5:00pm
8-K
1mf0 aeonk
16 Nov 22
Entry into a Material Definitive Agreement
5:08pm
8-K
icxmfr35xs985 a8vjo2
14 Nov 22
Jaguar Health Provides Company Updates and Reports 2022 Third Quarter Financials
8:01am
8-K
a34sq24d9wqznf
21 Oct 22
Entry into a Material Definitive Agreement
4:00pm
8-K
3tcz64vrpkssah
14 Oct 22
Entry into a Material Definitive Agreement
4:29pm
8-K
p6l hidt5enc3yz5q
30 Sep 22
Jaguar Health Reports Voting Results from 2022 Special Meeting of Stockholders
4:45pm
8-K
j6ac xbcfkpav
30 Aug 22
Jaguar Health Secures Additional Capital Through Sale of Royalty Rights Related to Future Crofelemer and Lechlemer Revenue Stream
4:30pm
8-K
bk1db9ds
23 Aug 22
Entry into a Material Definitive Agreement
4:30pm
8-K
si5fclzb2 ka3
19 Aug 22
Jaguar Health Receives Additional 180-day Grace Period to Regain Compliance with Nasdaq’s Bid Price Rule
8:00am
8-K
vshh d9iiqx4ahoagzpg
18 Aug 22
Unregistered Sales of Equity Securities
3:48pm
8-K
zm38jh2v9
26 Jul 22
Entry into a Material Definitive Agreement
7:00am
8-K
la4dapj1auc0zhu5sdn
20 Jul 22
Entry into a Material Definitive Agreement
5:10pm
8-K
mo7 zv5ee9
6 Jul 22
Greg Divis departs from Jaguar’s Board of Directors; Experienced business development executive Rachel Zolot Schwartz chairs new committee
4:30pm
8-K
kgxbkkeg8vnd6opt7sw
29 Jun 22
Entry into a Material Definitive Agreement
8:30am
8-K
ke0v1ta5lbwy5db1
10 Jun 22
Jaguar Health Reports Voting Results from 2022 Annual Meeting of Stockholders
5:00pm
8-K
iz6eql
10 May 22
Jaguar Health Provides Company Updates and Reports 2022 First Quarter Financials
8:00am
8-K
42jm tdm7
15 Apr 22
Entry into a Material Definitive Agreement
4:16pm
8-K
y0nx yzeid6b4
1 Apr 22
Departure of Directors or Certain Officers
4:57pm
8-K
cwjei2xf 2bkpe7tq
18 Mar 22
Amendments to Articles of Incorporation or Bylaws
4:30pm
8-K
gcpkei d6a
15 Mar 22
Unregistered Sales of Equity Securities
7:00am